Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableStudy completedNCT07146815
What this trial is testing

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)Polycystic Ovarian Syndrome (PCOS)
Ziekenhuis Oost-Limburg 157
Not applicableUnknownNCT05301231
What this trial is testing

Omics-based Predictors of NAFLD/Potential NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
National Research Centre, Egypt 450
Not applicableStudy completedNCT01966627
What this trial is testing

Genetics of Fatty Liver Disease in Children

Who this might be right for
Non Alcoholic Fatty Liver Disease
Yale University 381
Not applicableUnknownNCT05971082
What this trial is testing

Risk Factors for Advanced Fibrosis Among FLD Patients

Who this might be right for
NAFLDLiver CirrhosisDiabetes Mellitus, Type 2
Helsinki University Central Hospital 1,000
Early research (Phase 1)Ended earlyNCT07052682
What this trial is testing

Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

Who this might be right for
Steatohepatitis
Takeda 11
Testing effectiveness (Phase 2)Study completedNCT05804305
What this trial is testing

Misoprostol for NASH

Who this might be right for
NASH
Ziauddin University 50
Not applicableActive Not RecruitingNCT04383951
What this trial is testing

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Indiana University 40
Not applicableStudy completedNCT03663062
What this trial is testing

ObeSity Related Colorectal Adenoma Risk

Who this might be right for
Colorectal AdenomaColorectal NeoplasmColorectal Cancer+4 more
South Tyneside and Sunderland NHS Foundation Trust 1,430
Not applicableStudy completedNCT04270656
What this trial is testing

Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis

Who this might be right for
Type 2 Diabetes (T2D)
Nantes University Hospital 46
Not applicableStudy completedNCT03985020
What this trial is testing

Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Children's Hospital Los Angeles 20
Early research (Phase 1)Study completedNCT04686994
What this trial is testing

Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

Who this might be right for
Overweight and ObesityNAFLDHyperlipidemia
Gannex Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00668070
What this trial is testing

A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831

Who this might be right for
Non-Alcoholic Steatohepatitis
Astellas Pharma Inc 114
Not applicableWithdrawnNCT05130346
What this trial is testing

Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicObesity
Virginia Commonwealth University
Not applicableLooking for participantsNCT07376486
What this trial is testing

Duodenal pulsENDO as an Early Treatment for Type 2 DM

Who this might be right for
Diabete MellitusT2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Chinese University of Hong Kong 40
Not applicableWithdrawnNCT03163810
What this trial is testing

See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Erchonia Corporation
Not applicableStudy completedNCT06338618
What this trial is testing

Manual Therapy in Metabolic Liver Disease

Who this might be right for
NAFLD, Non-alcoholic Fatty Liver Disease
University of Seville 42
Not applicableLooking for participantsNCT03535142
What this trial is testing

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMetabolic EncephalopathyObesity, Morbid+1 more
Esbjerg Hospital - University Hospital of Southern Denmark 1,200
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Not applicableEnrolling By InvitationNCT07564947
What this trial is testing

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Who this might be right for
MAFLDFatty LiverFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD+4 more
University of Agriculture, Peshawar 40
Next Page